ARK discloses 5.33% stake in GeneDx Holdings
GeneDx Holdings Corp. (WGS) received an amended Schedule 13G filing reporting that ARK Investment Management LLC and its CEO/CIO Catherine D. Wood beneficially own 1,581,810 shares of GeneDx common stock, representing 5.33% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GeneDx Holdings Corp. (WGS) received an amended Schedule 13G filing reporting that ARK Investment Management LLC and its CEO/CIO Catherine D. Wood beneficially own 1,581,810 shares of GeneDx common stock, representing 5.33% of the class.
ARK reports sole voting power over 1,493,030 shares and shared voting power over 22,855 shares. ARK has sole dispositive power over 1,581,810 shares. Catherine D. Wood reports shared voting power over 1,515,885 shares and shared dispositive power over 1,581,810 shares.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in GeneDx Holdings Corp. (WGS) is reported by ARK Investment Management LLC?
What is Catherine D. Wood’s reported ownership position in GeneDx (WGS)?
What is the difference between ARK’s and Catherine D. Wood’s voting power in GeneDx (WGS)?
What percentage of GeneDx (WGS) common stock is beneficially owned by ARK and Catherine D. Wood?
Who signed the amended Schedule 13G for GeneDx (WGS) on behalf of ARK?
AI-generated analysis. How Rhea-AI works. Not financial advice.